News >

Preventing Progression and Chasing Cure in Smoldering Myeloma

Kristi Rosa
Published: Wednesday, Aug 14, 2019

Maria-Victoria Mateos, MD, hematologist and director of the Myeloma unit at the University Hospital of Salamanca

Maria-Victoria Mateos, MD

Data from several clinical trials support treatment with lenalidomide (Revlimid) plus low-dose dexamethasone in select patients with high-risk smoldering multiple myeloma to prevent disease progression, said Maria-Victoria Mateos, MD, adding that other promising combinations under investigation are showing curative potential.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Individualizing Treatment After Second-Line Therapy for Patients With mCRCAug 29, 20191.0
Community Practice Connections™: Immunotherapeutic Strategies with the Potential to Transform Treatment for Genitourinary CancersAug 29, 20191.0
Publication Bottom Border
Border Publication